-+ 0.00%
-+ 0.00%
-+ 0.00%

Lyell Immunopharma Launches Phase 3 Trial Comparing Ronde-cel to Approved CAR T Therapies in Large B-Cell Lymphoma

Reuters·02/12/2026 12:35:31

Please log in to view news